Bliss GVS Pharma Ltd. Financials

NSE BSE

15:59 Jul 18

Bliss GVS Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

160.74

+4.18 (+2.67%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

160.74

+4.18 (+2.67%)
15:59 Jul 18

Quality

62/100
High Financial Strength

Valuation

50/100
Mid Valuation

Technical

55/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Net Sales	577.21	747.45	751.59	770.24	809.73
Operating Expenses +	470.56	629.12	634.27	619.62	683.04
Raw Material	340.79	420.18	374.38	390.47	421.79
Increase Decrease in Cost	-11.88	-29.2	26.94	-8.35	-8.11
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	68.09	76.15	86.17	95.58	112.05
Miscellaneous Expenses	235.52	231.81	235.46	244.62	255.87
Operating Profit	106.65	118.33	117.32	150.62	126.69
Other Income	20.22	31.49	17.79	28.74	36.49
Depreciation	17.23	17.33	18.67	26.38	29.42
Interest	5.51	4.74	10.36	6.91	8.12
Profit before tax and exceptio..	104.13	127.76	106.07	146.07	125.64
Exceptional Items	0	-73.59	0	-29.2	0
PBT	104.13	54.17	106.07	116.87	125.64
Provision for Taxation	30.16	31.04	29.34	35.29	35.38
Net Profit	73.97	23.13	76.73	81.58	90.26
NET Profit after MI	68.49	15.04	70.86	75.45	84.3
EPS	6.64	1.46	6.72	7.23	7.95
Operating Profit Margin (%)	18.48	15.83	15.61	19.55	15.65
Net Profit Margin (%)	11.87	2.01	9.43	9.8	10.41

All Data in Percentage (%)

	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24
Promoter	35.30	35.10	34.80	34.90	35.00
FII	13.20	13.50	12.10	13.20	14.70
MF	0.00	0.00	0.00	0.00	0.00
Others	6.50	6.60	6.60	6.60	6.60

Promoter Non-Promoter

Shareholder	Shares	Holding %

Download Our App On: